Screener Summaries Updates Institutions Sign In More Updates › Other Events › DYAI Other Events · Jul 24, 2026
Dyadic International, Inc. announced on July 24, 2026, that Nasdaq has confirmed the company's compliance with Nasdaq… DYAI Dyadic International Inc
Dyadic International, Inc. announced on July 24, 2026, that Nasdaq has confirmed the company's compliance with Nasdaq Listing Rules 5550(a)(2) and 5550(b), ensuring its common stock will continue to be listed and traded on the Nasdaq Capital Market. Dyadic Applied BioSolutions is a biotechnology company developing recombinant protein production platforms.
More from Dyadic International Inc Nasdaq notifies Dyadic International of deficiency notice for failing to maintain $1 minimum bid price and $35M MVLS Sep 25, 2026 Dyadic International, Inc. entered into agreements on August 13, 2026, to raise approximately $2.9 million in gross… Aug 14, 2026 Dyadic International reported second-quarter 2026 financial results for the period ended June 30, 2026 Aug 12, 2026 Dyadic International, Inc. held its 2026 Annual Meeting of Shareholders on June 18, 2026 Jun 22, 2026 Dyadic International, Inc. received a notification from Nasdaq on June 18, 2026, initiating delisting proceedings due… Jun 18, 2026 All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.
Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.
© 2026 go-intrinsic.com. All rights reserved.
